20151125-IR-845150416NIA OVERVIEW: Adds 845 IAC 2 to establish standards and protocols for the prescribing of controlled substances by podiatrists, consistent with standard medical practices in pain management treatment, inc...

TITLE 845 BOARD OF PODIATRIC MEDICINE

Notice of Intent to Adopt a Rule LSA Document #15-416

Under IC 4-22-2-23, the Board of Podiatric Medicine intends to adopt a rule concerning the following:

OVERVIEW: Adds 845 IAC 2 to establish standards and protocols for the prescribing of controlled substances by podiatrists, consistent with standard medical practices in pain management treatment, including the use of abuse deterrent formulations. Public comments are invited and may be directed to the Indiana Board of Podiatric Medicine: Darren R. Covington, J.D., Director, 402 West Washington Street, Room W072, Indianapolis, Indiana 46204 or by e-mail to [e-mail]. Statutory authority: IC 25-22.5-13-3; IC 25-29.

For purposes of IC 4-22-2-28.1, the Small Business Regulatory Coordinator for this rule is:

Darren R. Covington, J.D.

Indiana Professional Licensing Agency

Indiana Government Center South

402 West Washington Street, Room W072

Indianapolis, IN 46204

[phone]

[e-mail]

For purposes of IC 4-22-2-28.1, the Small Business Ombudsman designated by IC 4-4-35-8 is:

Erik Scheub

Office of Small Business and Entrepreneurship

One North Capitol, Suite 600

Indianapolis, IN 46204

[phone]

[e-mail]

Resources available to regulated entities through the small business ombudsman include the ombudsman's duties stated in IC 4-4-35-8, specifically IC 4-4-35-8(9), investigating and attempting to resolve any matter regarding compliance by a small business with a law, rule, or policy administered by a state agency, either as a party to a proceeding or as a mediator.

Posted: 11/25/2015 by Legislative Services Agency

DIN: 20151125-IR-845150416NIA

Composed: Nov 01,2016 2:06:53AM EDT

A PDF version of this document.